See more : Vixtel Technologies Holdings Limited (1782.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Ziccum AB (publ) (ZICC.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ziccum AB (publ), a leading company in the Biotechnology industry within the Healthcare sector.
- Umiya Tubes Limited (UMIYA.BO) Income Statement Analysis – Financial Results
- Mijem Newcomm Tech Inc. (MJEM.CN) Income Statement Analysis – Financial Results
- Kansas City Southern (KSU) Income Statement Analysis – Financial Results
- Sampre Nutritions Limited (SAMPRE.BO) Income Statement Analysis – Financial Results
- TOCCA Life Holdings, Inc. (TLIF) Income Statement Analysis – Financial Results
Ziccum AB (publ) (ZICC.ST)
About Ziccum AB (publ)
Ziccum AB (publ) develops dry powder preparations of biological pharmaceuticals. It develops and commercializes LaminarPace, a spray drying technology that dries chemicals, vaccines, biologics, and drug substances at room temperature. The company was founded in 2017 and is headquartered in Lund, Sweden.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 3.75M | 17.00K | 5.00K | 5.00K | 654.00K | 227.00K | 0.00 |
| Cost of Revenue | 27.03M | 1.37M | 11.13M | 13.42M | 7.67M | 3.98M | 173.33K |
| Gross Profit | -23.29M | -1.36M | -11.12M | -13.42M | -7.02M | -3.75M | -173.33K |
| Gross Profit Ratio | -621.46% | -7,976.47% | -222,460.00% | -268,320.00% | -1,073.39% | -1,652.42% | 0.00% |
| Research & Development | 0.00 | 0.00 | 208.00K | 209.00K | 208.00K | 209.00K | 0.00 |
| General & Administrative | 0.00 | 0.00 | 11.13M | 13.42M | 7.67M | 3.98M | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 27.88M | 27.60M | 11.13M | 13.42M | 7.67M | 3.98M | 0.00 |
| Other Expenses | 0.00 | 28.96M | 9.99M | 3.81M | 1.05M | 460.00K | 0.00 |
| Operating Expenses | 27.88M | 28.96M | 21.12M | 17.24M | 8.72M | 4.44M | 277.33K |
| Cost & Expenses | 27.88M | 28.96M | 21.12M | 17.24M | 8.72M | 4.44M | 450.67K |
| Interest Income | 148.00K | 167.00K | 20.00K | 54.00K | 2.00K | 0.00 | 68.00K |
| Interest Expense | 0.00 | 167.00K | 20.00K | 54.00K | 2.00K | 361.00K | 0.00 |
| Depreciation & Amortization | 1.22M | 1.37M | 634.00K | 182.00K | 43.00K | 227.00K | 277.33K |
| EBITDA | -20.34M | -27.58M | -20.27M | -16.84M | -8.68M | -3.98M | -173.33K |
| EBITDA Ratio | -542.89% | -138,505.88% | -405,480.00% | -336,880.00% | -1,295.11% | -1,755.07% | 0.00% |
| Operating Income | -21.56M | -28.96M | -21.12M | -17.24M | -8.72M | -4.21M | -450.67K |
| Operating Income Ratio | -575.39% | -170,323.53% | -422,320.00% | -344,700.00% | -1,333.49% | -1,854.63% | 0.00% |
| Total Other Income/Expenses | 148.00K | 167.00K | -20.00K | -54.00K | -2.00K | -361.00K | -68.00K |
| Income Before Tax | -21.41M | -28.79M | -21.14M | -17.29M | -8.72M | -4.57M | -518.67K |
| Income Before Tax Ratio | -571.44% | -169,341.18% | -422,720.00% | -345,780.00% | -1,333.79% | -2,014.10% | 0.00% |
| Income Tax Expense | 0.00 | -334.00K | 20.00K | 54.00K | 2.00K | -1.00K | 0.00 |
| Net Income | -21.41M | -28.45M | -21.16M | -17.34M | -8.73M | -4.57M | -518.67K |
| Net Income Ratio | -571.44% | -167,376.47% | -423,120.00% | -346,860.00% | -1,334.10% | -2,013.66% | 0.00% |
| EPS | -1.54 | -2.05 | -1.91 | -2.05 | -1.45 | -1.27 | -0.19 |
| EPS Diluted | -1.54 | -2.05 | -1.91 | -2.05 | -1.45 | -1.27 | -0.19 |
| Weighted Avg Shares Out | 13.87M | 13.86M | 11.05M | 8.45M | 6.03M | 3.60M | 2.69M |
| Weighted Avg Shares Out (Dil) | 13.87M | 13.86M | 11.05M | 8.45M | 6.03M | 3.60M | 2.69M |
Source: https://incomestatements.info
Category: Stock Reports